Search results for "030226 pharmacology & pharmacy"

showing 10 items of 317 documents

In vivo models and decision trees for formulation development in early drug development: A review of current practices and recommendations for biopha…

2018

The ability to predict new chemical entity performance using in vivo animal models has been under investigation for more than two decades. Pharmaceutical companies use their own strategies to make decisions on the most appropriate formulation starting early in development. In this paper the biopharmaceutical decision trees available in four EFPIA partners (Bayer, Boehringer Ingelheim, Bristol Meyers Squibb and Janssen) were discussed by 7 companies of which 4 had no decision tree currently defined. The strengths, weaknesses and opportunities for improvement are discussed for each decision tree. Both pharmacokineticists and preformulation scientists at the drug discovery & development interf…

Chemistry PharmaceuticalDecision treePharmaceutical ScienceBiological Availability02 engineering and technology030226 pharmacology & pharmacyBiopharmaceutics03 medical and health sciences0302 clinical medicineDrug DevelopmentIn vivoNew chemical entityDrug DiscoveryAnimalsHumansBiological ProductsManagement scienceDrug discoveryDecision TreesGeneral Medicine021001 nanoscience & nanotechnologyClinical trialIdentification (information)BiopharmaceuticalDrug development0210 nano-technologyBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Disso…

2020

Dissolution is a crucial process for the oral delivery of drug products. Before being absorbed through epithelial cell membranes to reach the systemic circulation, drugs must first dissolve in the human gastrointestinal (GI) tract. In vivo and in vitro dissolutions are complex because of their dependency upon the drug physicochemical properties, drug product, and GI physiological properties. However, an understanding of this process is critical for the development of robust drug products. To enhance our understanding of in vivo and in vitro dissolutions, a hierarchical mass transfer (HMT) model was developed that considers the drug properties, GI fluid properties, and fluid hydrodynamics. T…

Chemistry PharmaceuticalDiffusionPharmaceutical Science02 engineering and technologyBuffers030226 pharmacology & pharmacyDiffusion03 medical and health sciences0302 clinical medicineMass transferDrug DiscoveryDissolution testingParticle SizeSolubilityDissolutionChemistryCheminformaticsHydrogen-Ion Concentration021001 nanoscience & nanotechnologyShear rateDrug LiberationKineticsModels ChemicalSolubilityChemical engineeringHydrodynamicsMolecular MedicineParticleParticle size0210 nano-technologyMolecular Pharmaceutics
researchProduct

Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals

2018

The purpose of this study was to evaluate the effect of charge on the in vitro drug performances of clarithromycin nanocrystals. To prepare different charges of nanocrystals, media milling was employed with the use of different stabilizing systems. The uncharged nanocrystals were prepared from poloxamer 407. The negatively and positively charged nanocrystals were stabilized using a combination of poloxamer 407 with sodium lauryl sulfate (SLS) and cetyltrimethylammonium bromide (CTAB), respectively. After production, the particle size of the negatively and positively charged nanocrystals was smaller than that of the uncharged one. The similar particle size of variously charged clarithromycin…

Chemistry PharmaceuticalDrug CompoundingPharmaceutical SciencePoloxamer02 engineering and technology030226 pharmacology & pharmacyCell LineExcipients03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBromideClarithromycinMonolayermedicineHumansSurface chargeParticle SizeSolubilityDissolutionCetrimoniumChemistrySodium Dodecyl SulfateBiological TransportGeneral Medicine021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationSolubilityChemical engineeringNanocrystalPoloxamer 407NanoparticlesParticle sizeCaco-2 Cells0210 nano-technologyBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.

2017

Food induced viscosity can delay disintegration and subsequent release of API from solid dosage form which may lead to severe reduction in the bioavailability of BCS type III compounds. Formulations of such tablets need to be optimized in view of this postprandial viscosity factor. In this study, three super disintegrants, croscarmellose sodium (CCS), cross-linked polyvinylpolypyrrolidone (CPD), and sodium starch glycolate (SSG) were assessed for their efficiency under simulated fed state. Tablets containing these disintegrants were compressed at 10 and 30 KN, while taking lactose as a soluble filler. In addition to other compendial tests, disintegration force of these formulations was meas…

Chemistry PharmaceuticalPharmaceutical ScienceLactose02 engineering and technology030226 pharmacology & pharmacyDosage formExcipients03 medical and health sciencesViscosity0302 clinical medicineDrug DiscoverySodium Starch GlycolateImmediate releaseDissolutionPharmacologyFOOD EFFECTChemistryViscosityOrganic Chemistryfood and beveragesPovidoneStarch021001 nanoscience & nanotechnologyBioavailabilityChemical engineeringSolubilityFoodCarboxymethylcellulose Sodium0210 nano-technologyFederal stateTabletsDrug development and industrial pharmacy
researchProduct

2020

In this study, the potential for correlation between disintegration and dissolution performance of enteric-coated (EC) dosage forms was investigated. Different enteric hard shell capsule formulations containing caffeine as model drug were tested for disintegration (in a compendial disintegration tester) and for dissolution in both USP type I (basket) and type II (paddle) apparatuses using different media. Overall, good correlations were obtained. This was observed for both the basket and the paddle apparatus, indicating that the use of disintegration testing as a surrogate for dissolution testing (allowed by International Conference on Harmonization (ICH) for immediate release dosage forms …

ChromatographyChemistryPharmaceutical ScienceCapsule02 engineering and technology021001 nanoscience & nanotechnologyPositive correlation030226 pharmacology & pharmacySmall intestineDosage formIn vitro03 medical and health sciences0302 clinical medicinemedicine.anatomical_structuremedicineDissolution testingImmediate release0210 nano-technologyDissolutionPharmaceutics
researchProduct

Multicomponent solid dispersion as a formulation strategy to improve drug permeation: A case study on the anti-colorectal cancer irinotecan

2019

Abstract Multicomponent solid dispersions (MSD)s are frequently proposed as efficient drug delivery systems to improve drug solubility and bioavailability. In this study, the effects of specific excipients, such as mannitol, inulin, poly(methyl methacrylate-co-methacrylic)acid (PMMA) and cellulose acetate phthalate (CAP) have been tested to potentially improve irinotecan (IRN) permeation in the intestinal tract with the intention to protect the drug from the gastric environment. MSDs were formulated as microparticles by Spray-Drying technique. Raw materials and microparticles have been characterized by FTIR analysis to determine hydrogen bonding. SEM images were recorded to investigate morp…

ChromatographyPharmaceutical Science02 engineering and technologyPermeation021001 nanoscience & nanotechnology030226 pharmacology & pharmacyBioavailabilityMulticomponent solid dispersion Microparticles Irinotecan Inulin Spray-drying03 medical and health scienceschemistry.chemical_compound0302 clinical medicineCellulose acetate phthalatechemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryDissolution testingParticle sizeSolubility0210 nano-technologyDissolutionJournal of Drug Delivery Science and Technology
researchProduct

Biosensor-based kinetic and thermodynamic characterization of opioids interaction with human μ-opioid receptor.

2019

Development of opioid analgesics with minimal side effects requires substantial knowledge on structure-kinetic and -thermodynamic relationship of opioid-receptor interactions. Here, combined kinetics and thermodynamics of opioid agonist binding to human μ-opioid receptor (h-μOR) was investigated using real-time label-free surface plasmon resonance (SPR)-based method. The N-terminal end truncated and C-terminal 6His-tagged h-μOR was constructed and expressed in E. coli. Receptor was purified, detergent-solubilized and characterized by circular dichroism. The uniform immobilization of h-μOR on Ni-NTA chips was achieved using hybrid capture-coupling approach followed by reconstitution in lipid…

Circular dichroismThermodynamic equilibriummedicine.drug_classEnthalpyReceptors Opioid muPharmaceutical Science02 engineering and technology(+)-NaloxoneBiosensing Techniques030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineOpioid receptormedicineEscherichia coliHumansSurface plasmon resonanceLipid bilayerMorphineChemistryNaloxone021001 nanoscience & nanotechnologyAnalgesics OpioidKineticsOpioidBiophysicsThermodynamics0210 nano-technologymedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy

2020

[EN] Colonic Drug Delivery Systems (CDDS) are especially advantageous for local treatment of inflammatory bowel diseases (IBD). Site-targeted drug release allows to obtain a high drug concentration in injured tissues and less systemic adverse effects, as consequence of less/null drug absorption in small intestine. This review focused on the reported contributions in the last four years to improve the effectiveness of treatments of inflammatory bowel diseases. The work concludes that there has been an increase in the development of CDDS in which pH, specific enzymes, reactive oxygen species (ROS), or a combination of all of these triggers the release. These delivery systems demonstrated a th…

ColonAdministration OralReview02 engineering and technologyDiseaseIntestinal permeabilityInflammatory bowel diseasesPharmacology030226 pharmacology & pharmacyInflammatory bowel diseaseCatalysislcsh:ChemistryInorganic Chemistry03 medical and health sciencesDrug Delivery SystemsQUIMICA ORGANICA0302 clinical medicineIn vivoQUIMICA ANALITICAmedicineAnimalsHumansPhysical and Theoretical ChemistryMesalamineAdverse effectlcsh:QH301-705.5Molecular BiologySpectroscopyIntestinal permeabilitybusiness.industryQUIMICA INORGANICAOrganic ChemistryInflammatory Bowel DiseasesGeneral MedicineColitis021001 nanoscience & nanotechnologymedicine.diseaseSmall intestineComputer Science ApplicationsAminosalicylic AcidsDrug Liberationmedicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999Drug deliveryDrug delivery0210 nano-technologybusinessInternational Journal of Molecular Sciences
researchProduct

Preclinical models for colonic absorption, application to controlled release formulation development.

2018

Oral controlled release (CR) formulations have many benefits and have become a valuable resource for the local and systemic administration of drugs. The most important characteristic of these pharmaceutical products is that drug absorption occurs mainly in the colon. Therefore, this review analyses the physiological and physicochemical features that may affect an orally administered CR product, as well as the different strategies to develop a CR dosage form and the methods used to evaluate the formulation efficacy. The models available to study the intestinal permeability and their applicability to colonic permeability determinations are also discussed.

ColonDrug Evaluation PreclinicalPharmaceutical ScienceAdministration Oral02 engineering and technologyPharmacology030226 pharmacology & pharmacyModels BiologicalDosage form03 medical and health sciences0302 clinical medicinemedicineOral routeAnimalsHumansIntestinal permeabilityChemistryGeneral Medicine021001 nanoscience & nanotechnologymedicine.diseaseControlled releaseColonic absorptionIntestinal AbsorptionPharmaceutical PreparationsControlled-Release FormulationsDelayed-Action PreparationsDrug DesignSystemic administration0210 nano-technologyBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Correlation study of GAPDH, Bcl-2, and Bax protein immunoexpression in patients with colorectal adenocarcinoma.

2018

Introduction Colorectal cancer (CRC) is the third and second most commonly diagnosed cancer worldwide in males and females, respectively. Despite prominent progress in diagnosis and treatment, the recurrence rates are still high. A tumour hypoxic environment leads to an increase in glycolytic metabolism. The crucial intermediate component of glycolysis, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), could play a significant role in cancer progression. An increased level of GAPDH has been described in oncogene-induced transformation and anti-apoptotic function. In other studies, GAPDH has been involved in apoptosis induction. Aim We examined colorectal adenocarcinoma samples to assess the…

Colorectal cancerLymphovascular invasionlcsh:Medicinecolorectal cancer02 engineering and technology030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineDownregulation and upregulationstomatognathic systemBcl-2 proteinsmedicineGlycolysisGlyceraldehyde 3-phosphate dehydrogenaseOriginal Paperbiologybusiness.industryhypoxialcsh:RGastroenterologyapoptosisCancerglycolysis021001 nanoscience & nanotechnologymedicine.diseasePrimary and secondary antibodiesApoptosisbiology.proteinCancer research0210 nano-technologybusinessPrzeglad gastroenterologiczny
researchProduct